PPARGC1A and chronic kidney disease: Low PGC-1α expression in acute kidney injury (AKI) and CKD has been observed, while PGC-1α overexpression was related to a protective effect in vivo and in vitro AKI models (nephrotoxic, ischemic-reperfusion, and septic) [10,45,46,47].